|
2022
|
Invention
|
Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder ca... |
|
|
Invention
|
Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer.
The inventi... |
|
2020
|
Invention
|
Prevention of infectious diseases by modulating the immune system. The invention relates to a rec... |
|
2019
|
Invention
|
Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer. Mycobacteriu... |
|
|
Invention
|
Viral particle-based vaccine. The present invention relates to nucleic acid molecules encoding a ... |
|
|
Invention
|
Viral particle - based vaccine. The present invention relates to nucleic acid molecules encoding ... |
|
2016
|
Invention
|
Mycobacterium as an immunotherapeutic agent for the treatment of cancer. Mycobacterium cell for u... |
|
|
Invention
|
Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer. The inventio... |
|
|
Invention
|
Mycobacterium as a vaccine. Mycobacterium cell for use as a vaccine. |
|
2012
|
Invention
|
Composition containing hcmv particles.
The present invention is related to a composition compris... |
|
2011
|
Invention
|
Recombinant mycobacterium as a vaccine. Mycobacterium cell for use as a vaccine. |
|
|
Invention
|
Determination of the efficacy of an anti-mycobacterial vaccination. The invention relates to meth... |
|
|
Invention
|
Recombinant mycobacterium as a vaccine. The invention relates to a recombinant Mycobacterium cell... |
|
|
Invention
|
Recombinant mycobacterium as vaccine for use in humans. The invention relates to a recombinant va... |
|
|
Invention
|
Type-1 interferons for treatment of multiple sclerosis. The invention relates to the field of mul... |
|
|
Invention
|
Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) contai... |
|
2010
|
Invention
|
Method for producing an immunotherapeutic agent. The invention relates to a method for producing ... |
|
2008
|
Invention
|
Composition containing hcmv particles. The present invention is related to a composition comprisi... |
|
2005
|
Invention
|
Combination of a bacterial cell and a biologically active agent. The present invention is related... |
|
|
Invention
|
Combination of a recombinant mycobacterium and a biologically active agent as a vaccine. The pres... |
